Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Global Crown Capital Announces Nanotechnology Index Quarterly Rebalance

Abstract:
(Bloomberg: GCCLGCNI)

Global Crown Capital Announces Nanotechnology Index Quarterly Rebalance

SAN FRANCISCO, CA | Posted on April 17th, 2008

The 1Q08 rebalancing of the Global Crown Capital Nanotechnology Index added five new stocks while removing four, increasing the total number of components in the index to 29. The five newly added components are Applera Corp. (ABI), Bruker Corp. (BRKR), CombiMatrix Corp. (CBMX), and Nanosphere, Inc. (NSPH). The components removed from the index no longer qualify, as they are trading below the $1.00 per share threshold. The removed components are Acusphere (ACUS), Immunicon Corp. (IMMC), Nanogen Inc. (NGEN), and Psvidia ADR (PSDV).

During 1Q08 the GCC Nanotechnology Index declined 6.5%, outperforming both NASDAQ-100 and S&P 500 indices by 6.6% and 2.1%, respectively. The best performing stock was Illumina (ILMN), moving up 28.1%. The worst performing stock was Altair Nanotechnologies (ALTI), dropping 37.6%. The average daily trading volume is over 500,000 shares and the total market cap of the index is over $32 billion.

The GCC Nanotechnology Index is designed to track the stock performance of the nanotechnology industry. Many companies are active in nanotechnology, but only those public companies whose stock performance GCC believes moves with the success or failure of its nanotechnology efforts are eligible for inclusion. Large multi-national corporations are often spending on nanotechnology research and have nanotechnology-enabled product lines, but if GCC believes their stock prices move mainly for reasons other than nanotechnology, they are not included. Similarly stocks which trade below $1.00 or are not on a national U.S. exchange are not eligible.

As the nanotechnology industry evolves, the list of the companies included in the GCC Nanotechnology Index changes. The number of components included in the index can increase or decrease depending on the number of U.S. public companies primarily focused on nanotechnology (IPO, mergers and acquisitions, or refocusing of business activities).

####

About Global Crown Capital, LLC
Global Crown Capital, LLC is a research-focused boutique investment firm broadly and deeply focused on technology. The firm specializes in Global Equity Research, Institutional Sales and Trading, Prime Brokerage, Global Wealth Management, Asset Management, Investment Banking and Corporate Services. GCC is a member of FINRA/NFA/SIPC.

For more information, please click here

Contacts:
Global Crown Capital, LLC
Helen Simms
415-354-7183

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project